What we're reading, March 8, 2016: rate of unplanned pregnancies in the US is at a 30-year low; doctors told they are overprescribing addictive medicines don't change their behavior; and despite Obamacare, surprise medical bills find a way.
The rate of unplanned pregnancies in the US has reached its lowest level in 30 years. While there are some variations in rates by income, race, ethnicity, education, and age, the rates declined in almost every demographic group, according to The New York Times. While changes in contraceptive use are thought to be driving the decline, 81% of pregnancies among women who were cohabiting were still considered unintentional in 2011.
When doctors are told that they are overprescribing addictive drugs, they don’t change prescribing habits. According to Reuters, government letters to doctors prescribing more addictive drugs than their peers had no impact. This is different from previous research that has found sending letters that compared doctors with their peers has encouraged them to vaccinate patients.
While the Affordable Care Act has made some progress against surprise medical bills, there are 2 big loopholes, reported TIME. First, patients could receive a separate bill after a medical emergency from the provider for whatever the insurer didn’t cover. Second, caps on out-of-pocket charges only include in-network care. But who is to blame? It’s not clear, but one of 3 groups could eventually be on the hook: insurance companies, the hospitals, or the physician lobby.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More